We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Professor Chris Bakal’s group uses genomic approaches and computational modelling to understand how complex biochemical signalling networks are ‘rewired’ during the development of cancer. Our goal is ...

We provided the first conclusive evidence that the basic cause of cancer is damage to DNA. The discovery changed scientific opinion dramatically and marked a turning point for cancer research. Until ...

We offer approximately 20 fully funded PhD studentships each year. Our main round opens in October, but we also advertise projects throughout the year. We provide a generous stipend and cover tuition ...

Established in 2007, the NIHR BRC funds and supports innovative translational research, meaning that it takes leading-edge cancer research from the laboratory and rapidly translates it into clinical ...

Our multidisciplinary centres of excellence and strategic collaborations bring a critical mass of leading researchers together from across the ICR, The Royal Marsden and partner institutions to tackle ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

The Cancer Epidemiology and Prevention Research Unit (CEPRU) is a joint initiative between The Institute of Cancer Research, ...

An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite you to join us to hear from leading ...

We provide exceptional opportunities for the best scientists, clinicians, and professional and administrative staff, and excellent academic and recreational facilities at our two London sites, in ...